Skip to content
★ Sign in to follow
JS

James S. Kuo

Duska Therapeutics, Inc.Theriva Biologics, Inc.
Total declarations
5
Companies
2
▲ Purchases (5 ops.)
€3,273
▼ Sales (0 ops.)
—

Latest filing published 31 Aug 2011 for Theriva Biologics, Inc., €2,150.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 31 Aug 2011 · 5548 days ago · €2,150
    +201.5%
    Entry US$5,862.50 · Close at T+365 US$17,675.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

James S. Kuo: trading record in brief

James S. Kuo has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Duska Therapeutics, Inc. and Theriva Biologics, Inc. Between 6 December 2007 and 30 August 2011, the trades on record add up to 5 filings.

The open-market record is one-sided, with 5 purchases worth €3,273 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2011 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €375 and half below.

The latest filing, published on 31 August 2011, reports an open-market purchase of €2,150 in Theriva Biologics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to James S. Kuo

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    Chairman, CEO & PresidentExecutivesTheriva Biologics, Inc.
    3,103 USD0SEC
    4,500 shares@ US$0.6895Common stockSEC:0001144204-11-050839:0
    Canonical exit: 28 Nov 2011 (T+90)
  • ▲
    Chief Executive OfficerExecutivesDuska Therapeutics, Inc.
    310 USD0SEC
    1,000 shares@ US$0.31DUSKA Common StockSEC:0001213900-08-001728:0
    Canonical exit: 2 Dec 2008 (T+90)
  • ▲
    Chief Executive OfficerExecutivesDuska Therapeutics, Inc.
    180 USD0SEC
    900 shares@ US$0.20DUSKA Common StockSEC:0001213900-08-001682:0
    Canonical exit: 23 Nov 2008 (T+90)
  • ▲
    Chief Executive OfficerExecutivesDuska Therapeutics, Inc.
    600 USD0SEC
    2,000 shares@ US$0.30DUSKA Common StockSEC:0001213900-08-001686:0
    Canonical exit: 25 Nov 2008 (T+90)
  • ▲
    Chief Executive OfficerExecutivesDuska Therapeutics, Inc.
    550 USD0SEC
    1,000 shares@ US$0.55DUSKA Common StockSEC:0001144204-07-066531:0
    Canonical exit: 5 Mar 2008 (T+90)

5 of 5 declarations